ClinicalTrials.Veeva

Menu

Procleix® Dengue Virus Assay Testing of Individual Donor Samples From Puerto Rican and US Blood Donors - CTS

G

Gen-Probe

Status

Completed

Conditions

Dengue

Treatments

Device: Procleix Dengue Virus Assay

Study type

Observational

Funder types

Industry

Identifiers

NCT01702272
DENVTS-US12-002

Details and patient eligibility

About

The objective of this study is to test individual donor samples (IDSs) with the investigational Dengue Assay on the TIGRIS System and to further characterize the Dengue Assay in the clinical setting.

Enrollment

150,000 estimated patients

Sex

All

Volunteers

Accepts Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:

  • Donor must meet all the blood collection sites' standard eligibility requirements.
  • Donor and/or legally authorized representative must be willing to undergo the site's routine informed consent process prior to study participation.

Trial design

150,000 participants in 1 patient group

Dengue Virus
Treatment:
Device: Procleix Dengue Virus Assay

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems